The signal-averaged P-wave duration is longer in hypertensive patients with history of paroxysmal atrial fibrillation as compared to those without

2005 ◽  
Vol 103 (1) ◽  
pp. 37-40 ◽  
Author(s):  
Kudret Aytemir ◽  
Basri Amasyali ◽  
Gulcan Abali ◽  
Sedat Kose ◽  
Ayhan Kilic ◽  
...  
2000 ◽  
Vol 23 (7) ◽  
pp. 1127-1132 ◽  
Author(s):  
GEORGE K. ANDRIKOPOULOS ◽  
POLYCHRONIS E. DILAVERIS ◽  
DIMITRIS J. RICHTER ◽  
ELIAS J. GIALAFOS ◽  
ANDREAS G. SYNETOS ◽  
...  

EP Europace ◽  
2020 ◽  
Vol 22 (9) ◽  
pp. 1337-1344
Author(s):  
Matthias Daniel Zink ◽  
Winnie Chua ◽  
Stef Zeemering ◽  
Luigi di Biase ◽  
Bayes de Luna Antoni ◽  
...  

Abstract Aims Freedom from atrial fibrillation (AF) at 1 year can be achieved in 50–70% of patients undergoing catheter ablation. Recurrent AF early after ablation most commonly terminates spontaneously without further interventional treatment but is associated with later recurrent AF. The aim of this investigation is to identify clinical and procedural factors associated with recurrence of AF early after ablation. Methods and results We retrospectively analysed data for recurrence of AF within the first 3 months after catheter ablation from the randomized controlled AXAFA–AFNET 5 trial, which demonstrated that continuous anticoagulation with apixaban is as safe and as effective compared to vitamin K antagonists in 678 patients undergoing first AF ablation. The primary outcome of first recurrent AF within 90 days was observed in 163 (28%) patients, in which 78 (48%) patients experienced an event within the first 14 days post-ablation. After multivariable adjustment, a history of stroke/transient ischaemic attack [hazard ratio (HR) 1.54, 95% confidence interval (CI) 0.93–2.6; P = 0.11], coronary artery disease (HR 1.85, 95% CI 1.20–2.86; P = 0.005), cardioversion during ablation (HR 1.78, 95% CI 1.26–2.49; P = 0.001), and an age:sex interaction for older women (HR 1.01, 95% CI 1.00–1.01; P = 0.04) were associated with recurrent AF. The P-wave duration at follow-up was significantly longer for patients with AF recurrence (129 ± 31 ms vs. 122 ± 22 ms in patients without AF, P = 0.03). Conclusion Half of all early AF recurrences within the first 3 months post-ablation occurred within the first 14 days post-ablation. Vascular disease and cardioversion during the procedure are strong predictors of recurrent AF. P-wave duration at follow-up was longer in patients with recurrent AF. Trial registration Clinicaltrials.gov identifier NCT02227550


2001 ◽  
Vol 88 (7) ◽  
pp. 795-798 ◽  
Author(s):  
Takahisa Yamada ◽  
Masatake Fukunami ◽  
Tsuyoshi Shimonagata ◽  
Kazuaki Kumagai ◽  
Yoshihiro Asano ◽  
...  

2017 ◽  
Vol 119 (2) ◽  
pp. 275-279 ◽  
Author(s):  
Giulio Conte ◽  
Adrian Luca ◽  
Sasan Yazdani ◽  
Maria Luce Caputo ◽  
François Regoli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document